S R Ytterberg Selected Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis)

1/2017	Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.
9/2013	Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
1/2009	Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S R Ytterberg Research Topics

Disease

3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 01/2009
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017 - 09/2013
2	Vasculitis (Vasculitides) 11/2014 - 09/2013
1	Infections 01/2017
1	Microscopic Polyangiitis 01/2017
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2015
1	Dermatomyositis (Dermatopolymyositis) 10/2015
1	Polymyositis 10/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2009

Drug/Important Bio-Agent (IBA)

4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 01/2009
2	Myeloblastin (Proteinase 3)IBA 01/2017 - 01/2009
2	Rituximab (Mabthera)FDA Link 11/2014 - 09/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	AntibodiesIBA 01/2017
1	EnzymesIBA 01/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Histidine-tRNA LigaseIBA 10/2015
1	AutoantibodiesIBA 10/2015
1	Jo-1 antibodyIBA 10/2015
1	HLA-DRB1*03:01 antigenIBA 10/2015
1	HLA-B Antigens (HLA-B)IBA 10/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013
1	Azathioprine (Imuran)FDA LinkGeneric 09/2013
1	Prednisone (Sone)FDA LinkGeneric 09/2013
1	AutoantigensIBA 01/2009
1	CarbohydratesIBA 01/2009
1	AntigensIBA 01/2009

Therapy/Procedure

1	Therapeutics 09/2013
1	Remission Induction 09/2013